top of page
.webp)
Global Cancer Technology
Global Cancer Technology Common Stock 2
GCT’s lead cancer technology is its remote-controlled cancer drug delivery platform.
There is a newer open investment round for this company - click here to view
Our take:
Sign up to receive weekly deal alerts and top news
Round Performance

Amount Raised
[]

Average Investment
[]

Average Per Day
[]

# of Investors
[]
Investors vs. Capital Raised
Investment Type
Common Stock
Round Valuation
$26,682,636
Minimum Investment
$100
Price Per Share
$2
Investment Details
Early Bird Perks
Perk description | Perk level (dollars) | Perk level (days) |
---|
Loading...
Similar Investments
Geoship
SAFE
KALIA HEALTH
OPTICYTE
bottom of page